Placebo for moxifloxacin
Sponsors
GlaxoSmithKline, Tibotec Pharmaceuticals, Ireland, Purdue Pharma LP, MedDay Pharmaceuticals SA, Altavant Sciences GmbH
Conditions
Carcinoma, Renal CellElectrocardiographyHealthyHealthy VolunteersHepatitis CObesityOverweight
Phase 1
VEG111485: A QTc Study of Pazopanib
CompletedNCT00861029
Start: 2009-03-19End: 2010-02-15Updated: 2017-11-14
TMC435-TiDP16-C117: The Effect of TMC435 on the Results of Electrocardiograms (Electric Recording of the Heart) in Healthy Volunteers
CompletedNCT01269294
Start: 2011-01-31End: 2011-07-31Updated: 2013-05-06
The Effect of Hydrocodone Bitartrate (HYD) Extended-Release Tablets on QT /QTc Intervals in Healthy Adult Subjects
CompletedNCT02243241
Start: 2012-11-30End: 2013-05-31Updated: 2014-09-17
TQT2 Study to Evaluate the Effect of MD1003 on Cardiac Repolarization in Healthy Adult Subjects
NCT04168723
Start: 2019-11-11End: 2020-03-05Target: 64Updated: 2020-02-20
Thorough QT Study to Evaluate the Effect of Rodatristat Ethyl, Rodatristat and Its Major Metabolites on the Heart
CompletedNCT05933447
Start: 2023-05-12End: 2023-07-28Updated: 2023-10-03
A Study to Assess the Effect of Avacopan at Therapeutic and Supratherapeutic Doses on the QT/QTc Interval in Healthy Participants
CompletedNCT05988034
Start: 2019-11-08End: 2020-03-31Updated: 2023-08-14
Effect of Maridebart Cafraglutide on the Heart's Electrical Activity
Active, not recruitingNCT07229157
Start: 2025-10-22End: 2026-08-26Updated: 2026-01-23